Literature DB >> 34463389

Neurocutaneous melanocytosis-associated malignant melanoma presenting with peritoneal seeding.

Ugur Sener1, Kevin Elmore2, Keerthana Jayaseelan3, Joanne Porter4, Ashfaq Marghoob5, Marc K Rosenblum6, Sofia Haque7, Yasmin Khakoo8,9.   

Abstract

Neurocutaneous melanocytosis (NCM) is characterized by melanocyte deposition in the leptomeninges and brain parenchyma, primarily occurring in children with large or giant congenital melanocytic nevi (LCMN) or multiple congenital melanocytic nevi. Patients with NCM may develop hydrocephalus and increased intracranial pressure, which can be managed with ventriculoperitoneal (VP) shunting. We present the case of a 16-month-old girl who developed peritoneal carcinomatosis and malignant ascites following VP shunting for hydrocephalus secondary to NCM to increase awareness of this rare, but serious, complication of cerebrospinal fluid diversion.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  meningeal carcinomatosis; neoplasms malignant; neurocutaneous disorders; nevi-melanocytic; peritoneal carcinomatosis

Mesh:

Year:  2021        PMID: 34463389      PMCID: PMC9429811          DOI: 10.1111/pde.14789

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.997


  24 in total

1.  Leptomeningeal metastases in the MRI era.

Authors:  J L Clarke; H R Perez; L M Jacks; K S Panageas; L M Deangelis
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

2.  Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi--results from the NYU-LCMN registry.

Authors:  E K Hale; J Stein; L Ben-Porat; K S Panageas; M S Eichenbaum; A A Marghoob; I Osman; A W Kopf; D Polsky
Journal:  Br J Dermatol       Date:  2005-03       Impact factor: 9.302

3.  Spectrum of central nervous system abnormalities in neurocutaneous melanocytosis.

Authors:  Vijay Ramaswamy; Holly Delaney; Sofia Haque; Ashfaq Marghoob; Yasmin Khakoo
Journal:  Dev Med Child Neurol       Date:  2012-04-02       Impact factor: 5.449

4.  New insights into neurocutaneous melanosis.

Authors:  Ketsuda Jakchairoongruang; Yasmin Khakoo; Mark Beckwith; A James Barkovich
Journal:  Pediatr Radiol       Date:  2018-08-03

Review 5.  Extracranial, peritoneal seeding of primary malignant brain tumors through ventriculo-peritoneal shunts in children: Case report and review of the literature.

Authors:  Anand Narayan; George Jallo; Thierry A G M Huisman
Journal:  Neuroradiol J       Date:  2015-10-06

6.  Classification of neurological abnormalities in children with congenital melanocytic naevus syndrome identifies magnetic resonance imaging as the best predictor of clinical outcome.

Authors:  R Waelchli; S E Aylett; D Atherton; D J Thompson; W K Chong; V A Kinsler
Journal:  Br J Dermatol       Date:  2015-08-27       Impact factor: 9.302

Review 7.  Neurocutaneous melanosis presenting with hydrocephalus and malignant transformation: case-based update.

Authors:  F Sharouf; M Zaben; A Lammie; P Leach; M I Bhatti
Journal:  Childs Nerv Syst       Date:  2018-06-12       Impact factor: 1.475

8.  Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis.

Authors:  Hye Seon Kim; Jong Bae Park; Ho-Shin Gwak; Ji-Woong Kwon; Sang-Hoon Shin; Heon Yoo
Journal:  World J Surg Oncol       Date:  2019-03-27       Impact factor: 2.754

9.  Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi.

Authors:  S Polubothu; N McGuire; L Al-Olabi; W Baird; N Bulstrode; J Chalker; D Josifova; D Lomas; J O'Hara; J Ong; D Rampling; P Stadnik; A Thomas; E Wedgeworth; N J Sebire; V A Kinsler
Journal:  Br J Dermatol       Date:  2019-08-09       Impact factor: 9.302

10.  Changes in Cerebral Partial Oxygen Pressure and Cerebrovascular Reactivity During Intracranial Pressure Plateau Waves.

Authors:  Erhard W Lang; Magdalena Kasprowicz; Peter Smielewski; John Pickard; Marek Czosnyka
Journal:  Neurocrit Care       Date:  2015-08       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.